Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00964678 · ClinicalTrials.gov registry record · Phase 1
Pilot Study of the Safety and Efficacy of Carvedilol in Pulmonary Arterial Hypertension
A Phase 1 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00964678 is a Phase 1 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 10 participants.
The verdict
NCT00964678, a Phase 1 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether carvedilol treatment of patients with pulmonary arterial hypertension and associated right heart failure is safe and results in an improved function of the right heart.
Interventions
- DRUG Carvedilol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2010-06 |
| Est. Completion | 2014-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00964678
The ClinicalTrials.gov registry entry for NCT00964678 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Carvedilol is the first listed.
NCT00964678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00964678 about?
NCT00964678 is a clinical study titled "Pilot Study of the Safety and Efficacy of Carvedilol in Pulmonary Arterial Hypertension". The purpose of this study is to determine whether carvedilol treatment of patients with pulmonary arterial hypertension and associated right heart failure is safe and results in an improved function of the right heart.
What is the current status of trial NCT00964678?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2010-06. Estimated completion is 2014-05.
What interventions are being tested in trial NCT00964678?
The interventions under investigation include: Carvedilol (DRUG).
Who is sponsoring clinical trial NCT00964678?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.